AC Immune announces that they have received a research grant from Goradia Family to support extending Part 1 of the ongoing Phase 2 VacSYn trial of ACI-7104, an active anti-alpha-synuclein immunotherapy (vaccine), in early #Parkinsons
ir.acimmune.com/news-release...
